Filing Details
- Accession Number:
- 0001209191-19-004449
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-17 20:48:41
- Reporting Period:
- 2019-01-15
- Accepted Time:
- 2019-01-17 20:48:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1593353 | Hung Do | C/O Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 | Chief Science Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-15 | 4,400 | $2.94 | 452,713 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 3,800 | $5.13 | 456,513 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-15 | 16,600 | $12.00 | 439,913 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-01-16 | 4,988 | $2.94 | 444,901 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-01-16 | 30,036 | $5.13 | 474,937 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-16 | 36,669 | $12.05 | 438,268 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2019-01-15 | 4,400 | $0.00 | 4,400 | $2.94 |
| Common Stock | Stock Options (right to buy) | Disposition | 2019-01-15 | 3,800 | $0.00 | 3,800 | $5.13 |
| Common Stock | Stock Options (right to buy) | Disposition | 2019-01-16 | 4,988 | $0.00 | 4,988 | $2.94 |
| Common Stock | Stock Options (right to buy) | Disposition | 2019-01-16 | 30,036 | $0.00 | 30,036 | $5.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,988 | 2024-06-26 | No | 4 | M | Direct | |
| 66,821 | 2027-01-03 | No | 4 | M | Direct | |
| 0 | 2024-06-26 | No | 4 | M | Direct | |
| 36,785 | 2027-01-03 | No | 4 | M | Direct |
Footnotes
- The sale of common stock was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018.
- This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.00 to $12.23. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- All of the options were fully vested and exercisable as of January 15, 2019.
- These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 3, 2018. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2018, with the final installment vesting on January 1, 2021.
Billionaire Hedge Funds
